Abrogation of cell-mediated immunity by hyperimmune alloantiserum: mechanisms and correlation with allograft enhancement.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000032:analysis; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D001202:Ascitic Fluid / Q000276:immunology; D002850:Chromatography, Gel; D002860:Chromium Radioisotopes; D003601:Cytotoxicity Tests, Immunologic; D000939:Epitopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007518:Isoantibodies; D007519:Isoantigens; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D012509:Sarcoma / Q000276:immunology
D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D002860:Chromium Radioisotopes; D000939:Epitopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007518:Isoantibodies; D007519:Isoantigens